Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | PAM | P19021 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3812372 | 1.00 | DNM1 (0.44) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL28344983 | 1.00 | DNM1 (0.44) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL3812373 | 1.00 | DNM1 (0.44) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL3812312 | 1.00 | DNM1 (0.44) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL1884255 | 1.00 | DNM1 (0.44) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL27529876 | 0.98 | DNM1 (0.43) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL3813150 | 0.98 | DNM1 (0.41) | DNM1DGKASPHK2SPHK1LMNA | |
| SCHEMBL21404095 | 0.92 | NOS3 (0.38) | DNM1ALDH1A1TSHR | |
| SCHEMBL3818372 | 0.92 | FAAH (0.53) | LMNAMAPTMEN1FAAHTP53 | |
| SCHEMBL21404051 | 0.92 | FAAH (0.53) | LMNAMAPTMEN1FAAHTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7511164-B2 | Enhanced bioavailability; reacting creatine, fatty acid and thionyl halide | MULTI FORMULATIONS LTD (CA) | 2009-03-31 | — | — | US | disclosed |
| US-20080200723-A1 | CREATINE-FATTY ACIDS | MULTI FORMULATIONS LTD. (CA) | 2008-08-21 | — | — | US | disclosed |
| US-7314945-B1 | Creatine-fatty acids | MULTI FORMULATIONS LTD. (CA) | 2008-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200723-A1 | CREATINE-FATTY ACIDS | FABP2, FABP3, FABP1 | DNM1 4580/4885DGKA 471/4885SPHK2 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.